Binding modes of decavanadate to myosin and inhibition of the actomyosin ATPase activity. | - CCMAR -

Journal Article

TitleBinding modes of decavanadate to myosin and inhibition of the actomyosin ATPase activity.
Publication TypeJournal Article
AuthorsTiago, T, Martel, P, Gutiérrez-Merino, C, Aureliano, M
Year of Publication2007
JournalBiochim Biophys Acta
Volume1774
Issue4
Date Published2007 Apr
Pagination474-80
ISSN0006-3002
KeywordsAnimals, Computational Biology, Computer Simulation, Dictyostelium, Models, Molecular, Myosins, Vanadates
Abstract

Decavanadate, a vanadate oligomer, is known to interact with myosin and to inhibit the ATPase activity, but the putative binding sites and the mechanism of inhibition are still to be clarified. We have previously proposed that the decavanadate (V(10)O(28)(6-)) inhibition of the actin-stimulated myosin ATPase activity is non-competitive towards both actin and ATP. A likely explanation for these results is that V(10) binds to the so-called back-door at the end of the Pi-tube opposite to the nucleotide-binding site. In order to further investigate this possibility, we have carried out molecular docking simulations of the V(10) oligomer on three different structures of the myosin motor domain of Dictyostelium discoideum, representing distinct states of the ATPase cycle. The results indicate a clear preference of V(10) to bind at the back-door, but only on the "open" structures where there is access to the phosphate binding-loop. It is suggested that V(10) acts as a "back-door stop" blocking the closure of the 50-kDa cleft necessary to carry out ATP-gamma-phosphate hydrolysis. This provides a simple explanation to the non-competitive behavior of V(10) and spurs the use of the oligomer as a tool to elucidate myosin back-door conformational changes in the process of muscle contraction.

DOI10.1016/j.bbapap.2007.02.004
Sapientia

http://www.ncbi.nlm.nih.gov/pubmed/17382607?dopt=Abstract

Alternate JournalBiochim. Biophys. Acta
PubMed ID17382607